financetom
Business
financetom
/
Business
/
Commerzbank Q2 net profit drops 5%, as expected; outlook confirmed
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Commerzbank Q2 net profit drops 5%, as expected; outlook confirmed
Aug 6, 2024 10:18 PM

FRANKFURT (Reuters) - Germany's Commerzbank said on Wednesday that net profit fell 4.8% in the second quarter, in line with expectations, and it confirmed its full-year targets.

Net profit of 538 million euros ($587 million) in the quarter compares with a profit of 565 million euros a year earlier. Analysts had on average expected a profit of 539 million euros, according to a July consensus forecast published by Commerzbank.

($1 = 0.9166 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AbbVie's Rinvoq shows superiority over Humira in head-to-head arthritis study
AbbVie's Rinvoq shows superiority over Humira in head-to-head arthritis study
Oct 20, 2025
Oct 20 (Reuters) - AbbVie ( ABBV ) said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller Humira in a head-to-head . AbbVie ( ABBV ) has been banking on its newer immunology drugs Skyrizi and Rinvoq to counter the drop in Humira sales due to a loss of exclusivity and competition from cheaper...
Cleveland-Cliffs CEO Sees Steel Demand Rebound Thanks To 'New Trade Environment'
Cleveland-Cliffs CEO Sees Steel Demand Rebound Thanks To 'New Trade Environment'
Oct 20, 2025
Cleveland-Cliffs Inc. ( CLF ) shares are trading higher premarket on Monday after the company reported third-quarter 2025 results. The steelmaker reported an adjusted loss of 45 cents per share, beating analysts’ expectations for a 48-cent loss. Revenue totaled $4.73 billion, missing the consensus estimate of $4.90 billion but up from $4.57 billion in the same quarter last year. Also Read: Cleveland-Cliffs (...
Rapt Therapeutics, Shanghai Jeyou Say Potential Autoimmune Therapy Effective at Longer Dose Intervals
Rapt Therapeutics, Shanghai Jeyou Say Potential Autoimmune Therapy Effective at Longer Dose Intervals
Oct 20, 2025
08:56 AM EDT, 10/20/2025 (MT Newswires) -- Rapt Therapeutics ( RAPT ) and Shanghai Jeyou Pharmaceutical said Monday that their jointly developed therapy RPT904 dosed at eight-week or 12-week intervals in a mid-stage trial was about as effective and safe as omalizumab dosed every four weeks. The companies said RPT904 was well tolerated with no serious adverse results related to...
Sector Update: Consumer
Sector Update: Consumer
Oct 20, 2025
08:54 AM EDT, 10/20/2025 (MT Newswires) -- Consumer stocks were steady premarket Monday, with the Consumer Discretionary Select Sector SPDR Fund (XLY) inactive and the Consumer Staples Select Sector SPDR Fund (XLP) up a slight 0.1%. Stellantis ( STLA ) Chief Executive Officer Antonio Filosa is to meet with Italian labor unions Monday, as the carmaker has paused production at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved